---
category: news
title: "BioXcel Therapeutics Receives FDA Breakthrough Therapy Designation for BXCL501 for the Acute ..."
excerpt: "BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology,"
publishedDateTime: 2021-03-15T11:02:00Z
originalUrl: "https://apnews.com/press-release/globenewswire-mobile/business-products-and-services-government-regulations-drug-approvals-coronavirus-pandemic-f497a4cc88cc898cfc0ec4cd0d14d3bc"
webUrl: "https://apnews.com/press-release/globenewswire-mobile/business-products-and-services-government-regulations-drug-approvals-coronavirus-pandemic-f497a4cc88cc898cfc0ec4cd0d14d3bc"
type: article
quality: 26
heat: 26
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "F9U4h9btBrikE3f6mCZ+ceWjfge0vFqclg8yNgwpNFqdu7g9u+i+E/awTNBL90iwUz0NrSOiPg0iHUByDSniTJzKx45VbxgjBUhjuHlerb3au31VEVJ7ioanVdWkrWJ5itQ2FyRGuM75k5rkEI9Gv9ObW+k/4diqJWwHZYZsoZktOn9TPIH2lQ21zybyPutTyir/wiQAfmNwQWUddKGaBdiw7YQX8vp9LDwaYwFAfblD3Ay6wRuus5/QhzMHr7FlVFWAHPUeoA/We4xKRkZ+SHFograLH0g799yfFG/mLOnfjTtqp3wSgjBEryV+BgVE7ucsPo4xmfd+rDZu5oL9TgVLky2dJMEiRuGMjlBPMUM=;479nccseIK9I4gYfcEGsqA=="
---

